查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1963658

大腸直腸癌篩檢市場：全球產業分析、規模、佔有率、成長、趨勢和預測（2025-2032 年）

Colon Screening Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
出版日期: | 出版商: Persistence Market Research | 英文 181 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

主要發現：

  • 大腸直腸癌篩檢市場規模（2025年預測）：187億美元
  • 預計市場規模（2032年）：244.5億美元
  • 全球市場成長率（2025年至2032年複合年成長率）：3.9%

大腸直腸癌篩檢市場研究範圍：

大腸直腸癌篩檢是指用於早期發現大腸直腸異常和大腸直腸癌（CRC）的診斷程序。大腸直腸癌是全球最常見且致死率最高的癌症之一。主要的篩檢技術包括糞便檢驗，例如糞便免疫化學檢查（FIT）和大便潛血試驗（FOBT）；大腸鏡檢查；乙狀結腸鏡檢查；以及膠囊內視鏡檢查。該市場涵蓋內視鏡、CT掃描儀、膠囊內視鏡、檢測套組和試劑等篩檢產品，這些產品供應給醫院、診斷和影像中心以及其他醫療機構。成長要素包括大腸直腸癌發病率的上升、意識提升的增強和預防措施的改進，以及診斷技術的進步。

市場成長因素：

全球大腸直腸癌篩檢市場的主要驅動力是大腸直腸癌發生率的不斷上升，這促使各國擴大篩檢計畫並加強早期檢測工作。截至2020年，大腸直腸癌是全球第三大常見癌症，當年新增病例估計達190萬例。據預測，到2040年，年新增病例數可能超過320萬例。各國政府、醫療衛生系統和公共衛生機構之間的合作旨在提高篩檢參與率、降低死亡率並減少長期治療成本。對非侵入性篩檢技術、遠端醫療整合以及人工智慧輔助內視鏡診斷的投資不斷增加，也進一步推動了市場成長。

市場限制：

儘管市場前景廣闊，但仍存在一些挑戰。某些篩檢方法，特別是糞便隱血大便潛血試驗(FIT) 和糞便大便潛血試驗試驗 (FOBT) 等非侵入性檢測，靈敏度有限，可能出現假陰性結果，尤其是在進行性腺瘤方面，因此需要進行後續大腸鏡檢查。這些限制可能會影響醫療專業人員對篩檢方法的選擇，並導致診斷延遲。區域監管的複雜性和報銷政策的差異也可能影響不同族群的篩檢普及率。

市場機會：

遠端醫療和更廣泛地提供居家檢測工具，使早期篩檢更加便捷易行，蘊藏著巨大的機會。包括Colosense和改良版ColoAlert在內的非侵入性糞便DNA和RNA檢測，將擴大篩檢範圍，尤其是在那些不願接受侵入性檢查的人群中。免費發放篩檢試劑盒和將人工智慧融入診斷等醫療保健舉措，有望促進市場滲透並提高患者依從性。

本報告解答的關鍵問題：

  • 推動全球大腸癌篩檢市場成長的關鍵因素有哪些？
  • 醫療保健系統中應用最廣泛的篩檢類型和產品有哪些？
  • 科技進步如何改變大腸直腸癌篩檢市場的競爭格局？
  • 全球大腸直腸癌篩檢市場的主要參與者有哪些？他們正在採取哪些策略來維持其市場地位？
  • 全球大腸直腸癌篩檢市場有哪些新興趨勢和未來前景？

目錄

第1章執行摘要

第2章 市場概覽

  • 市場範圍和定義
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 主要趨勢
  • 宏觀經濟因素
  • 新冠疫情影響分析
  • 預測因子－相關性和影響

第3章 加值見解

  • 工具採納分析
  • 監管狀態
  • 價值鏈分析
  • PESTLE分析
  • 波特五力分析

第4章 定價分析，2024年

  • 主要亮點
  • 影響實施成本的關鍵因素
  • 按產品類型進行價格分析

第5章 全球大腸癌篩檢市場展望

  • 主要亮點
    • 市場規模（單位）預測
    • 市場規模和年成長率
    • 絕對商機
  • 市場規模與銷售量（單位）分析與預測
    • 2019-2024年市場規模績效分析
    • 目前市場規模分析及預測（2025-2032年）
  • 全球大腸癌篩檢市場展望（依篩檢類型分類）
    • 引言/主要發現
    • 2019-2024年依篩檢類型分類的市場規模、表現及銷售量（單位）分析
    • 按篩檢類型分類的當前市場規模和銷售量（單位）分析及預測，2025-2032 年
      • 糞便檢驗
        • 糞便免疫化學檢查（FIT）
        • 癒創木脂大便潛血試驗（gFOBT）
        • 其他
      • 大腸鏡檢查
      • 軟性乙狀結腸鏡檢查
      • 膠囊內視鏡
      • 其他
    • 市場吸引力分析：篩檢類型
  • 全球大腸癌篩檢市場依產品類型展望
    • 引言/主要發現
    • 2019-2024年按產品類型分類的市場規模表現分析
    • 依產品類型分類的當前市場規模分析及預測（2025-2032年）
      • 內視鏡檢查
      • CT掃描儀
      • 膠囊內視鏡
      • 檢測套組和試劑
      • 其他
    • 按產品類型分類的市場吸引力分析
  • 全球大腸直腸癌篩檢市場展望：終端用戶
    • 引言/主要發現
    • 按最終用戶分類的市場規模績效分析，2019-2024 年
    • 按最終用戶分類的當前市場規模分析及預測（2025-2032 年）
      • 醫院
      • 診斷和影像中心
      • 研究和學術機構
      • 其他
    • 最終用戶市場吸引力分析

第6章 全球大腸直腸癌篩檢市場區域展望

  • 主要亮點
  • 2019年至2024年各地區市場規模表現及銷售量（單位）分析
  • 按地區分類的當前市場規模和銷售量（單位）分析與預測（2025-2032 年）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 按地區分類的市場吸引力分析

第7章 北美大腸癌篩檢市場展望

第8章 歐洲大腸癌篩檢市場展望

第9章 東亞大腸癌篩檢市場展望

第10章 南亞和大洋洲結直腸癌篩檢市場展望

第11章：拉丁美洲大腸癌篩檢市場展望

第12章 中東和非洲大腸癌篩檢市場展望

第13章 競爭格局

  • 2024年市佔率分析
  • 市場結構
    • 市場競爭格局分析
    • 競爭對手儀錶板
  • 公司簡介（詳情 - 概述、財務狀況、策略、近期發展）
    • Olympus Corporation
    • PENTAX Medical（Hoya Corporation）
    • FUJIFILM Holdings Corporation
    • Medtronic
    • Ambu A/S
    • Baxter（Hillrom &Welch Allyn）
    • EndoFresh
    • Bracco SpA
    • Varay Laborix
    • QuidelOrtho Corporation
    • Novigenix SA
    • Guardant Health, Inc.
    • Mainz Biomed NV
    • Eiken Chemical Co., Ltd.

第14章附錄

簡介目錄
Product Code: PMRREP35162

Persistence Market Research has recently released a comprehensive report on the colon screening market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global colon screening market from 2025 to 2032.

Key Insights:

  • Colon Screening Market Size (2025E): USD 18.7 Billion
  • Projected Market Value (2032F): USD 24.45 Billion
  • Global Market Growth Rate (CAGR 2025 to 2032): 3.9%

Colon Screening Market - Report Scope:

Colon screening involves diagnostic methods used for early detection of colorectal abnormalities and colorectal cancer (CRC), which is among the most common and fatal cancers worldwide. Major screening techniques include stool-based tests such as fecal immunochemical tests (FIT) and fecal occult blood tests (FOBT), colonoscopy, flexible sigmoidoscopy, capsule endoscopy, and others. The market covers screening products such as endoscopes, CT scanners, capsule endoscopes, and test kits & reagents, catering to hospitals, diagnostic & imaging centers, and other healthcare facilities. Growth is driven by rising CRC incidence, increasing awareness and preventive initiatives, and advancements in diagnostic technologies.

Market Growth Drivers:

The global colon screening market is primarily driven by the growing incidence of colorectal cancer, prompting expansion of national screening programs and early detection efforts. CRC was the third most common cancer globally in 2020, with an estimated 1.9 million new cases that year, and projections indicate cases may exceed 3.2 million annually by 2040. Alliances between governments, healthcare systems, and public health agencies aim to increase screening participation, reducing mortality and long-term treatment costs. Growing investments in non-invasive screening technologies, telemedicine integration, and AI-assisted endoscopic diagnostics further bolster market growth.

Market Restraints:

Despite the market's growth prospects, certain challenges exist. Sensitivity limitations of some screening methods, especially non-invasive tests such as FIT and FOBT, can lead to false negatives, particularly for advanced adenomas, necessitating follow-up colonoscopy tests. Such limitations may affect healthcare professionals' screening choices or result in delayed diagnosis. Regulatory complexities and variations in reimbursement policies across regions may also impact adoption rates among different population segments.

Market Opportunities:

Significant opportunities lie in expanding access to telemedicine and at-home testing tools, making early screening more convenient and accessible. Non-invasive stool DNA and RNA-based tests, including emerging products like Colosense and enhanced ColoAlert, expand screening reach, particularly among individuals reluctant to undergo invasive procedures. Healthcare initiatives distributing free screening kits and integrating AI into diagnostics are expected to enhance market penetration and patient compliance.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the colon screening market globally?
  • Which screening types and products are most widely adopted across healthcare systems?
  • How are technological advancements reshaping the competitive landscape of the colon screening market?
  • Who are the key players in the global colon screening market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global colon screening market?

Competitive Intelligence and Business Strategy:

Leading players in the colon screening market focus on enhancing diagnostic accuracy, expanding product offerings, and forging strategic collaborations to strengthen market presence. Companies leverage advanced imaging tools, AI-enabled endoscopy platforms, and telehealth solutions to improve early detection rates and patient outcomes. Partnerships with healthcare providers, government screening initiatives, and technology developers facilitate broader adoption of innovative screening solutions. Continuous R&D investments and new product launches are essential for sustaining competitive advantage.

Key Companies Profiled:

  • Olympus Corporation
  • PENTAX Medical (Hoya Corporation)
  • FUJIFILM Holdings Corporation
  • Medtronic
  • Ambu A/S
  • Baxter (Hillrom & Welch Allyn)
  • EndoFresh
  • Bracco
  • Varay Laborix
  • Guardant Health, Inc.
  • Novigenix SA
  • Eiken Chemical Co., Ltd.
  • Mainz Biomed N.V.

Colon Screening Market Research Segmentation:

By Screening Type

  • Stool-Based Tests
  • Fecal Immunochemical Test (FIT)
  • Guaiac-Based Fecal Occult Blood Test (gFOBT)
  • Colonoscopy
  • Flexible Sigmoidoscopy
  • Capsule Endoscopy
  • Others

By Product Type

  • Endoscopes
  • CT Scanners
  • Capsule Endoscopes
  • Test Kits & Reagents
  • Others

By End-user

  • Hospitals
  • Diagnostic & Imaging Centers
  • Research & Academic Institutions
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Colon Screening Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-economic Factors
    • 2.3.1. Global Sectoral Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Tool Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Deployment Costs
  • 4.3. Pricing Analysis, By Product Type

5. Global Colon Screening Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Colon Screening Market Outlook: Screening Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Screening Type, 2019 - 2024
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
      • 5.3.3.1. Stool-based Tests
        • 5.3.3.1.1. Fecal Immunochemical Test (FIT)
        • 5.3.3.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
        • 5.3.3.1.3. Others
      • 5.3.3.2. Colonoscopy
      • 5.3.3.3. Flexible Sigmoidoscopy
      • 5.3.3.4. Capsule Endoscopy
      • 5.3.3.5. Others
    • 5.3.4. Market Attractiveness Analysis: Screening Type
  • 5.4. Global Colon Screening Market Outlook: Product Type
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2024
    • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 5.4.3.1. Endoscopes
      • 5.4.3.2. CT Scanners
      • 5.4.3.3. Capsule Endoscopes
      • 5.4.3.4. Test Kits & Reagents
      • 5.4.3.5. Others
    • 5.4.4. Market Attractiveness Analysis: Product Type
  • 5.5. Global Colon Screening Market Outlook: End-user
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019 - 2024
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Diagnostic & Imaging Centers
      • 5.5.3.3. Research & Academic Institutions
      • 5.5.3.4. Others
    • 5.5.4. Market Attractiveness Analysis: End-user

6. Global Colon Screening Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Colon Screening Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 7.2.1. By Country
    • 7.2.2. By Screening Type
    • 7.2.3. By Product Type
    • 7.2.4. By End-user
    • 7.2.5. By Application
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 7.4.1. Stool-based Tests
      • 7.4.1.1. Fecal Immunochemical Test (FIT)
      • 7.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 7.4.1.3. Others
    • 7.4.2. Colonoscopy
    • 7.4.3. Flexible Sigmoidoscopy
    • 7.4.4. Capsule Endoscopy
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.5.1. Endoscopes
    • 7.5.2. CT Scanners
    • 7.5.3. Capsule Endoscopes
    • 7.5.4. Test Kits & Reagents
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic & Imaging Centers
    • 7.6.3. Research & Academic Institutions
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Colon Screening Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 8.2.1. By Country
    • 8.2.2. By Screening Type
    • 8.2.3. By Product Type
    • 8.2.4. By End-user
    • 8.2.5. By Application
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 8.4.1. Stool-based Tests
      • 8.4.1.1. Fecal Immunochemical Test (FIT)
      • 8.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 8.4.1.3. Others
    • 8.4.2. Colonoscopy
    • 8.4.3. Flexible Sigmoidoscopy
    • 8.4.4. Capsule Endoscopy
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.5.1. Endoscopes
    • 8.5.2. CT Scanners
    • 8.5.3. Capsule Endoscopes
    • 8.5.4. Test Kits & Reagents
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic & Imaging Centers
    • 8.6.3. Research & Academic Institutions
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Colon Screening Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 9.2.1. By Country
    • 9.2.2. By Screening Type
    • 9.2.3. By Product Type
    • 9.2.4. By End-user
    • 9.2.5. By Application
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 9.4.1. Stool-based Tests
      • 9.4.1.1. Fecal Immunochemical Test (FIT)
      • 9.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 9.4.1.3. Others
    • 9.4.2. Colonoscopy
    • 9.4.3. Flexible Sigmoidoscopy
    • 9.4.4. Capsule Endoscopy
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.5.1. Endoscopes
    • 9.5.2. CT Scanners
    • 9.5.3. Capsule Endoscopes
    • 9.5.4. Test Kits & Reagents
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic & Imaging Centers
    • 9.6.3. Research & Academic Institutions
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Colon Screening Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 10.2.1. By Country
    • 10.2.2. By Screening Type
    • 10.2.3. By Product Type
    • 10.2.4. By End-user
    • 10.2.5. By Application
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 10.4.1. Stool-based Tests
      • 10.4.1.1. Fecal Immunochemical Test (FIT)
      • 10.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 10.4.1.3. Others
    • 10.4.2. Colonoscopy
    • 10.4.3. Flexible Sigmoidoscopy
    • 10.4.4. Capsule Endoscopy
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.5.1. Endoscopes
    • 10.5.2. CT Scanners
    • 10.5.3. Capsule Endoscopes
    • 10.5.4. Test Kits & Reagents
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic & Imaging Centers
    • 10.6.3. Research & Academic Institutions
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Colon Screening Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 11.2.1. By Country
    • 11.2.2. By Screening Type
    • 11.2.3. By Product Type
    • 11.2.4. By End-user
    • 11.2.5. By Application
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 11.4.1. Stool-based Tests
      • 11.4.1.1. Fecal Immunochemical Test (FIT)
      • 11.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 11.4.1.3. Others
    • 11.4.2. Colonoscopy
    • 11.4.3. Flexible Sigmoidoscopy
    • 11.4.4. Capsule Endoscopy
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.5.1. Endoscopes
    • 11.5.2. CT Scanners
    • 11.5.3. Capsule Endoscopes
    • 11.5.4. Test Kits & Reagents
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic & Imaging Centers
    • 11.6.3. Research & Academic Institutions
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Colon Screening Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
    • 12.2.1. By Country
    • 12.2.2. By Screening Type
    • 12.2.3. By Product Type
    • 12.2.4. By End-user
    • 12.2.5. By Application
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Screening Type, 2025-2032
    • 12.4.1. Stool-based Tests
      • 12.4.1.1. Fecal Immunochemical Test (FIT)
      • 12.4.1.2. Guaiac-based Fecal Occult Blood Test (gFOBT)
      • 12.4.1.3. Others
    • 12.4.2. Colonoscopy
    • 12.4.3. Flexible Sigmoidoscopy
    • 12.4.4. Capsule Endoscopy
    • 12.4.5. Others
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 12.5.1. Endoscopes
    • 12.5.2. CT Scanners
    • 12.5.3. Capsule Endoscopes
    • 12.5.4. Test Kits & Reagents
    • 12.5.5. Others
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostic & Imaging Centers
    • 12.6.3. Research & Academic Institutions
    • 12.6.4. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Olympus Corporation
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Deployments
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. PENTAX Medical (Hoya Corporation)
    • 13.3.3. FUJIFILM Holdings Corporation
    • 13.3.4. Medtronic
    • 13.3.5. Ambu A/S
    • 13.3.6. Baxter (Hillrom & Welch Allyn)
    • 13.3.7. EndoFresh
    • 13.3.8. Bracco S.p.A.
    • 13.3.9. Varay Laborix
    • 13.3.10. QuidelOrtho Corporation
    • 13.3.11. Novigenix SA
    • 13.3.12. Guardant Health, Inc.
    • 13.3.13. Mainz Biomed N.V.
    • 13.3.14. Eiken Chemical Co., Ltd.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations